Chen, Haiyan <br/><br/>
Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors.  [electronic resource] 

 -  Drug design, development and therapy  2018 
 - 2097-2110 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1177-8881 
<br/><br/><label>Standard No.: </label>10.2147/DDDT.S169238  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibiotics, Antineoplastic--chemical synthesis<br/>Carbolines--chemical synthesis<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Dose-Response Relationship, Drug<br/>Down-Regulation--drug effects<br/>Doxorubicin--chemical synthesis<br/>Drug Design<br/>Drug Screening Assays, Antitumor<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred ICR<br/>Models, Molecular<br/>Molecular Structure<br/>Neoplasms, Experimental--drug therapy<br/>P-Selectin--antagonists & inhibitors<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--chemical synthesis<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Rats<br/>Rats, Sprague-Dawley<br/>Structure-Activity Relationship